Regeneron, US75886F1075

Regeneron stock trades at EUR 718.60 in weekend trading

Published on 10/24/2026 at 10:43 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Regeneron stock trades at EUR 718.60 in weekend trading on October 24, 2026. Results are scheduled for October 30.

Dates and developments ahead

  • Regeneron stock traded at EUR 718.60 at 10:39 a.m. CEST on October 24, 2026.
  • Regeneron announced a positive CHMP opinion for an updated Libtayo dosing schedule on October 16, 2026.
  • Regeneron and Sanofi announced an expanded antibody collaboration on October 1, 2026, including a USD 1 billion upfront payment.
  • Regeneron plans to report third-quarter 2026 results on October 30, 2026.
Regeneron Pharma US75886F1075 präsentiert eine stimmungsvolle Aquarell-Ansicht eines modernen Forschungscampus entlang eines ruhigen Flussufers, Illustration mit AI erstellt.

Regeneron stock traded at EUR 718.60 at 10:39 a.m. CEST on October 24, 2026, in weekend trading at Lang & Schwarz.

Weekend trading

Regeneron’s euro quote was EUR 718.60 at the recorded time. Xetra and the primary exchanges were closed during the weekend trading phase. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Regeneron stock.

Market context: Market report S&P 500.

The week in figures

The available market record places Regeneron’s weekend-trading price at EUR 718.60 on October 24, 2026. No additional weekly price figures are included here.

Company developments

On October 16, 2026, Regeneron Pharmaceuticals announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use had adopted a positive opinion recommending an alternative Libtayo dosing schedule. The recommendation supports a 700-milligram dose every six weeks after an initial 12-week regimen and an optional shorter infusion for the 350-milligram dose.

On October 1, 2026, Regeneron and Sanofi announced an expanded antibody collaboration. Regeneron is to receive a USD 1 billion upfront payment and may receive up to USD 7 billion in additional milestone payments. The companies said they will share development and commercialization costs and future profits equally for the new programs.

Dates ahead

Regeneron has announced that it will report third-quarter 2026 financial and operating results on October 30, 2026, before U.S. financial markets open. The company plans to hold a conference call and webcast at 8:30 a.m. Eastern Time that day.

Disclaimer...
en | US75886F1075 | REGENERON | boerse | 70403785 | bgmi